These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10211138)

  • 21. Olanzapine-induced tardive dystonia.
    Dunayevich E; Strakowski SM
    Am J Psychiatry; 1999 Oct; 156(10):1662. PubMed ID: 10518183
    [No Abstract]   [Full Text] [Related]  

  • 22. Tardive dystonia associated with olanzapine therapy.
    Gunal DI; Onultan O; Afsar N; Aktan S
    Neurol Sci; 2001 Aug; 22(4):331-2. PubMed ID: 11808858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug review "surprises" reader.
    Shulman RW
    Can Fam Physician; 2000 Dec; 46():2381-3. PubMed ID: 11153401
    [No Abstract]   [Full Text] [Related]  

  • 24. Ondansetron for tardive dyskinesia.
    Zullino DF; Eap CB; Voirol P
    Am J Psychiatry; 2001 Apr; 158(4):657-8. PubMed ID: 11282718
    [No Abstract]   [Full Text] [Related]  

  • 25. Olanzapine for schizophrenia.
    Med Lett Drugs Ther; 1997 Jan; 39(992):5-6. PubMed ID: 9008682
    [No Abstract]   [Full Text] [Related]  

  • 26. Switching antipsychotic medications.
    Weiden PJ; Aquila R; Dalheim L; Standard JM
    J Clin Psychiatry; 1997; 58 Suppl 10():63-72. PubMed ID: 9265919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First clinical experience with olanzapine (LY 170053): results of an open-label safety and dose-ranging study in patients with schizophrenia.
    Baldwin DS; Montgomery SA
    Int Clin Psychopharmacol; 1995 Nov; 10(4):239-44. PubMed ID: 8748045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Olanzapine in the treatment of tardive dyskinesia: a report of two cases.
    Soutullo CA; Keck PE; McElroy SL
    J Clin Psychopharmacol; 1999 Feb; 19(1):100-1. PubMed ID: 9934952
    [No Abstract]   [Full Text] [Related]  

  • 29. Side effect profiles of new antipsychotic agents.
    Casey DE
    J Clin Psychiatry; 1996; 57 Suppl 11():40-5; discussion 46-52. PubMed ID: 8941170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacologic treatment of first-episode schizophrenia: early intervention is key to outcome.
    DeQuardo JR
    J Clin Psychiatry; 1998; 59 Suppl 19():9-17. PubMed ID: 9847047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Olanzapine and improvement of tardive dyskinesia.
    Kucerová H
    Eur Psychiatry; 2002 Nov; 17(7):421-4. PubMed ID: 12547311
    [No Abstract]   [Full Text] [Related]  

  • 32. Severe akathisia during olanzapine treatment of acute schizophrenia.
    Jauss M; Schröder J; Pantel J; Bachmann S; Gerdsen I; Mundt C
    Pharmacopsychiatry; 1998 Jul; 31(4):146-8. PubMed ID: 9754850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The natural course of schizophrenia and effective maintenance drug treatment.
    Davis JM; Andriukaitis S
    J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):2S-10S. PubMed ID: 2870087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Olanzapine: efficacy in treating the positive and negative symptoms of schizophrenia.
    Gray R
    Ment Health Care; 1998 Feb; 1(6):193-4. PubMed ID: 9791411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Olanzapine in treatment-refractory schizophrenia: results of an open-label study. The Spanish Group for the Study of Olanzapine in Treatment-Refractory Schizophrenia.
    Martín J; Gómez JC; García-Bernardo E; Cuesta M; Alvarez E; Gurpegui M
    J Clin Psychiatry; 1997 Nov; 58(11):479-83. PubMed ID: 9413413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dosing the antipsychotic medication olanzapine.
    Nemeroff CB
    J Clin Psychiatry; 1997; 58 Suppl 10():45-9. PubMed ID: 9265916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Olanzapine-induced agranulocytosis.
    Naumann R; Felber W; Heilemann H; Reuster T
    Lancet; 1999 Aug; 354(9178):566-7. PubMed ID: 10470705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early relapse of psychotic symptoms after an initial response to olanzapine.
    Kostakoğlu AE; Rezaki M; Göğüş A
    Acta Psychiatr Scand; 1999 Oct; 100(4):312-4; discussion 314-5. PubMed ID: 10510702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improvement of tardive dyskinesia following treatment with olanzapine.
    Lykouras L; Malliori M; Christodoulou GN
    Eur Neuropsychopharmacol; 1999 Jun; 9(4):367-8. PubMed ID: 10422899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction of tardive dystonia with olanzapine.
    Jaffe ME; Simpson GM
    Am J Psychiatry; 1999 Dec; 156(12):2016. PubMed ID: 10588425
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.